Journal of Reproductive Immunology
Volume 85, Issue 1 , Pages 9-14 , May 2010

The impact of anti-HY responses on outcome in current and subsequent pregnancies of patients with recurrent pregnancy losses

  • Ole Bjarne Christiansen

      Affiliations

    • The Fertility Clinic 4071, University Hospital Copenhagen, Rigshospitalet, DK-2100 Copenhagen, Denmark
    • Department of Obstetrics and Gynaecology, Aalborg Hospital, Aarhus University Hospital, Denmark
    • Corresponding Author InformationCorresponding author at: Fertility Clinic 4071, Rigshospitalet, Copenhagen, Denmark. Fax: +45 35454946.
    • ,
  • Rudi Steffensen

      Affiliations

    • Department of Clinical Immunology, Aalborg Hospital, DK-9000 Aalborg, Denmark
    • ,
  • Henriette Svarre Nielsen

      Affiliations

    • The Fertility Clinic 4071, University Hospital Copenhagen, Rigshospitalet, DK-2100 Copenhagen, Denmark
    • Department of Obstetrics and Gynaecology, Aalborg Hospital, Aarhus University Hospital, Denmark

Received 28 August 2009 ,Revised 2 December 2009 ,Accepted 15 December 2009.

References 

  1. Adams KM, Yan Z, Stevens AM, Nelson JL. The changing maternal “self” hypothesis: a mechanism for maternal tolerance of the fetus. Placenta. 2007;28(5–6):378–382
  2. Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4+ CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J. Immunol. 2007;178:2572–2578
  3. Atkinson K, Farrell C, Chapman G, Downs K, Penny R, Biggs J. Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. Br. J. Haematol. 1986;63(2):231–239
  4. Carlens S, Ringden O, Remberger M, Lonnqvist B, Hagglund H, Klaesson S, et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant. 1998;22(8):755–761
  5. Christiansen OB, Pedersen B, Rosgaard A, Husth M. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum. Reprod. 2002;17(3):809–816
  6. Christiansen OB, Pedersen B, Nielsen HS, Nybo Andersen AM. Impact of the sex of first child on the prognosis in secondary recurrent miscarriage. Hum. Reprod. 2004;19(12):2946–2951
  7. Coulam CB. Immunological tests in the evaluation of reproductive disorders: a critical review. Am. J. Obstet. Gynecol. 1992;167:1844–1851
  8. de Bueger M, Bakker A, van Rood JJ, van der Woude F, Goulmy E. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J. Immunol. 1992;149(5):1788–1794
  9. Gale RP, Bortin MM, van Bekkum DW, Biggs JC, Dicke KA, Gluckman E, et al. Risk factors for acute graft-versus-host disease. Br. J. Haematol. 1987;67(4):397–406
  10. Gerber S, Vardhana S, Meagher-Villemure K, Vial Y, Hohlfeld P, Witkin SS. Association between fetal interleukin-1 receptor antagonist gene polymorphism and unexplained fetal death. Am. J. Obstet. Gynecol. 2005;193(4):1472–1477
  11. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J. Immunol. 2007;178(9):5949–5956
  12. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J. Exp. Med. 2006;203(9):2165–2175
  13. Gratwohl A, Hermans J, Niederwieser D, van Biezen A, van Houwelingen HC, Apperley J. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol. J. 2001;2(6):363–370
  14. Hambach L, Spierings E, Goulmy E. Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens. Best Pract. Res. Clin. Haematol. 2007;20(2):171–187
  15. Huppertz B, Kadyrov M, Kingdom JC. Apoptosis and its role in the trophoblast Am. J. Obstet. Gynecol. 2006;195(1):29–39
  16. James E, Chai JG, Dewchand H, Macchiarulo E, Dazzi F, Simpson E. Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood. 2003;102(1):388–393
  17. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98(7):2043–2051
  18. Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM, et al. Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 2006;12(7):758–769
  19. Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, Lee SJ, et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood. 2005;105(7):2973–2978
  20. Miklos DB, Kim HT, Zorn E, Hochberg EP, Guo L, Mattes-Ritz A, et al. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood. 2004;103(1):353–359
  21. Nielsen HS, Mogensen M, Steffensen R, Kruse C, Christiansen OB. Indications of anti-HY immunity in recurrent placental abruption. J. Reprod. Immunol. 2007;75:63–69
  22. Nielsen HS, Andersen AM, Kolte AM, Christiansen OB. A firstborn boy is suggestive of a strong prognostic factor in secondary recurrent miscarriage: a confirmatory study. Fertil. Steril. 2008;89(4):907–911
  23. Nielsen HS, Mortensen L, Nygaard U, Schnor O, Christiansen OB, Andersen AM. Brothers and reduction of the birth weight of later-born siblings. Am. J. Epidemiol. 2008;167(4):480–484
  24. Nielsen HS, Steffensen R, Varming K, van Halteren AG, Spierings E, Ryder LP, et al. Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy. Hum. Mol. Genet. 2009;18(9):1684–1691
  25. Nielsen HS, Mortensen L, Nygaard U, Schnor O, Christiansen OB, Andersen AMN. Sex of prior children and risk of stillbirth in subsequent pregnancies. Epidemiology. 2009;November 5 [Epub ahead of print]
  26. Ramalho MF, Garcia JM, Esper CR, Vantini R, Alves BC, Meida Junior IL, et al. Sexing of murine and bovine embryos by developmental arrest induced by high-titer H-Y antisera. Theriogenology. 2004;62(9):1569–1576
  27. Sargent IL, Wilkins T, Redman CW. Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet. 1988;2(8620):1099–1104
  28. Spierings E, Vermeulen CJ, Vogt MH, Doerner LE, Falkenburg JH, Mutis T, et al. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet. 2003;362(9384):610–615
  29. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu. Rev. Immunol. 2003;21:685–711
  30. van Els CA, Zantvoort E, Jacobs N, Bakker A, van Rood JJ, Goulmy E. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules. Bone Marrow Transplant. 1990;5(6):365–372
  31. van Els CA, D’Amaro J, Pool J, Blokland E, Bakker A, van Elsen PJ, et al. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics. 1992;35(3):161–165
  32. Verdijk RM, Kloosterman A, Pool J, van de Keur M, Naipal AM, van Halteren AG, et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood. 2004;103(5):1961–1964
  33. Zelenika D, Adams E, Mellor A, Simpson E, Chandler P, Stockinger B, et al. Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. J. Immunol. 1998;161(4):1868–1874
  34. Zorn E, Miklos DB, Floyd BH, Mattes-Ritz A, Guo L, Soiffer RJ, et al. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J. Exp. Med. 2004;199(8):1133–1142

PII: S0165-0378(10)00044-6

doi: 10.1016/j.jri.2009.12.008

Journal of Reproductive Immunology
Volume 85, Issue 1 , Pages 9-14 , May 2010

Article Tools

* Image Usage & Resolution